Cell & Gene Therapy Manufacturing Services Market Size

Cell & Gene Therapy Manufacturing Services Market size was over USD 7.2 billion in 2024 and is estimated to reach USD 58.6 billion by the end of 2037, expanding at a CAGR of 19.1% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of the cell & gene therapy manufacturing services is evaluated at USD 8.5 billion.

The growth is majorly due to the rising demand for advanced therapies fueled by the increasing prevalence of conditions such as cancer, neurological disorders, and inherited diseases. Furthermore, automation, AI, and closed-system manufacturing processes are being adopted to enhance capabilities.

Governments worldwide are also providing regulatory support for faster approvals, and funding several research programs. This is encouraging biotech and pharma companies to develop cell and gene therapies.  For instance, in October 2024, the 57^th Governor of New York State funded USD 430 million, for New York BioGenesis Park which is a Cell and Gene Therapy Innovation Hub, in Long Island. As the therapies progress for clinical trials and toward commercialization, there’s a greater need for specialized manufacturing services to support their production.